IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides-Reference-Cited by-同舟云学术

IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides

Published:2018-03-01 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Kanekiyo Shinsuke¹,Hazama Shoichi¹,Takenouchi Hiroko¹,Nakajima Masao¹,Shindo Yoshitaro¹,Matsui Hiroto¹,Tokumitsu Yukio¹,Tomochika Shinobu¹,Tsunedomi Ryouichi¹,Tokuhisa Yoshihiro¹,Iida Michihisa¹,Sakamoto Kazuhiko¹,Suzuki Nobuaki¹,Takeda Shigeru¹,Yamamoto Shigeru¹,Yoshino Shigefumi²,Okuno Kiyotaka³,Udaka Keiko⁴,Kawakami Yutaka⁵,Matsueda Satoko⁶,Ito Kyogo⁷,Nagano Hiroaki¹

Affiliation:

1. Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, Japan

2. Oncology Center, Yamaguchi University Hospital, Yamaguchi 755-8505, Japan

3. Department of Surgery, Kindai University Faculty of Medicine, Osaka 589-8511, Japan

4. Department of Immunology, School of Medicine, Kochi University, Kochi 780-8520, Japan

5. Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo 160-8582, Japan

6. Center for Immunotherapy Roswell Park Cancer Institute, Buffalo, NY 14263, USA

7. Cancer Vaccine Center, Kurume University, Kurume 839-0863, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor vaccines: Toward multidimensional anti-tumor therapies;Human Vaccines & Immunotherapeutics;2023-10-31

2. Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer;Pharmaceutics;2023-07-17

3. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review;Frontiers in Pharmacology;2023-04-21

4. Tumor-intrinsic YTHDF1 drives immune evasion and resistance to immune checkpoint inhibitors via promoting MHC-I degradation;Nature Communications;2023-01-17

5. Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines;Frontiers in Molecular Biosciences;2021-04-15